| Policy Number | Policy Title | Effective Date Start | Retire Date |
| CP.PHAR.466 | Valoctocogene Roxaparvovec-rvox (Roctavian) (PDF) | June 29, 2023 | November 1, 2026 |
| CP.PHAR.373 | Benralizumab (Fasenra) (PDF) | | November 1, 2026 |
| CP.PHAR.573 | Cabotegravir, Cabotegravir-Rilpivirine (Apretude Cabenuva) (PDF) | | September 1, 2026 |
| CP.PHAR.316 | Cabazitaxel (Jevtana®) (PDF) | | September 1, 2026 |
| CP.PHAR.416 | Caplacizumab-yhdp (Cablivi) (PDF) | | September 1, 2026 |
| CP.PHAR.533 | Ciltacabtagene Autoleucel (Carvykti) (PDF) | | September 1, 2026 |
| CP.PHAR.236 | Darbepoetin Alfa (Aranesp) (PDF) | | September 1, 2026 |
| CP.PHAR.237 | Epoetin Alfa (Epogen® and Procrit) (PDF) | | September 1, 2026 |
| CP.PHAR.238 | Methoxy polyethylene glycol-epoetin beta (Mircera) (PDF) | | September 1, 2026 |
| CP.PHAR.759 | Nerandomilast (Jascayd) (PDF) | | September 1, 2026 |
| CP.PHAR.140 | Pegvaliase-pqpz (Palynziq) (PDF) | | September 1, 2026 |
| CP.PHAR.103 | Immune Globulins (PDF) | | September 1, 2026 |
| CP.PHAR.01 | Omalizumab (Xolair) (PDF) | | June 1, 2026 |
